- $3.85bn
- $4.15bn
- $1.71bn
- 70
- 52
- 80
- 75
Annual income statement for PJT Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 992 | 1,026 | 1,153 | 1,493 | 1,714 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 745 | 789 | 945 | 1,190 | 1,351 |
| Operating Profit | 247 | 236 | 208 | 303 | 363 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 219 | 201 | 178 | 271 | 343 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 190 | 165 | 146 | 238 | 310 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 106 | 90.5 | 81.8 | 134 | 180 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 169 | 93.3 | 131 | 217 | 180 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.99 | 3.51 | 3.12 | 4.92 | 6.56 |
| Dividends per Share | |||||
| Special Dividends per Share |